| Anna Marie Scopellito-olsen, MD | |
|
25a June St Ste 111, Sanford, ME 04073-2642 | |
| (207) 490-7998 | |
| Not Available |
| Full Name | Anna Marie Scopellito-olsen |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 39 Years |
| Location | 25a June St Ste 111, Sanford, Maine |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003897935 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mainehealth Care At Home | Saco, ME | Home health agency |
| Hospice Of Southern Maine | Scarborough, ME | Hospice |
| Southern Maine Health Care | Biddeford, ME | Hospital |
| Maine Medical Center | Portland, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mainehealth | 7517860588 | 2067 |
News Archive
A quarter century after they discovered it, researchers have identified the job of one of the most common DNA-damage response proteins. The enzyme has puzzled scientists because it is present in nearly every organism, which suggests that it is crucial to life, and yet, in laboratory experiments, its function has remained a mystery.
A synthetic, anti-inflammatory and anti-allergic family of drugs to combat a variety of illnesses while avoiding detrimental side effects has been developed by a Hebrew University of Jerusalem researcher.
Working with mice and rabbits, Johns Hopkins scientists have found a way to block abnormal cholesterol production, transport and breakdown, successfully preventing the development of atherosclerosis, the main cause of heart attacks and strokes and the number-one cause of death among humans. The condition develops when fat builds inside blood vessels over time and renders them stiff, narrowed and hardened, greatly reducing their ability to feed oxygen-rich blood to the heart muscle and the brain.
Sirtex Medical Limited (ASX:SRX) today said sales of SIR-Spheres® microspheres, it's targeted radioactive treatment for inoperable liver cancer, grew 23% in the fourth quarter of the 2011 Financial Year compared with the same quarter last year. Full year dose sales grew 19.3% compared to a 14% growth the year before.
› Verified 3 days ago
| Entity Name | Mainehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790265502 PECOS PAC ID: 7517860588 Enrollment ID: O20040701000166 |
News Archive
A quarter century after they discovered it, researchers have identified the job of one of the most common DNA-damage response proteins. The enzyme has puzzled scientists because it is present in nearly every organism, which suggests that it is crucial to life, and yet, in laboratory experiments, its function has remained a mystery.
A synthetic, anti-inflammatory and anti-allergic family of drugs to combat a variety of illnesses while avoiding detrimental side effects has been developed by a Hebrew University of Jerusalem researcher.
Working with mice and rabbits, Johns Hopkins scientists have found a way to block abnormal cholesterol production, transport and breakdown, successfully preventing the development of atherosclerosis, the main cause of heart attacks and strokes and the number-one cause of death among humans. The condition develops when fat builds inside blood vessels over time and renders them stiff, narrowed and hardened, greatly reducing their ability to feed oxygen-rich blood to the heart muscle and the brain.
Sirtex Medical Limited (ASX:SRX) today said sales of SIR-Spheres® microspheres, it's targeted radioactive treatment for inoperable liver cancer, grew 23% in the fourth quarter of the 2011 Financial Year compared with the same quarter last year. Full year dose sales grew 19.3% compared to a 14% growth the year before.
› Verified 3 days ago
| Entity Name | Southern Maine Health Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659392819 PECOS PAC ID: 0143208348 Enrollment ID: O20040713001060 |
News Archive
A quarter century after they discovered it, researchers have identified the job of one of the most common DNA-damage response proteins. The enzyme has puzzled scientists because it is present in nearly every organism, which suggests that it is crucial to life, and yet, in laboratory experiments, its function has remained a mystery.
A synthetic, anti-inflammatory and anti-allergic family of drugs to combat a variety of illnesses while avoiding detrimental side effects has been developed by a Hebrew University of Jerusalem researcher.
Working with mice and rabbits, Johns Hopkins scientists have found a way to block abnormal cholesterol production, transport and breakdown, successfully preventing the development of atherosclerosis, the main cause of heart attacks and strokes and the number-one cause of death among humans. The condition develops when fat builds inside blood vessels over time and renders them stiff, narrowed and hardened, greatly reducing their ability to feed oxygen-rich blood to the heart muscle and the brain.
Sirtex Medical Limited (ASX:SRX) today said sales of SIR-Spheres® microspheres, it's targeted radioactive treatment for inoperable liver cancer, grew 23% in the fourth quarter of the 2011 Financial Year compared with the same quarter last year. Full year dose sales grew 19.3% compared to a 14% growth the year before.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Anna Marie Scopellito-olsen, MD 96 Midland Rd, Staten Island, NY 10308-2918 Ph: (718) 668-6963 | Anna Marie Scopellito-olsen, MD 25a June St Ste 111, Sanford, ME 04073-2642 Ph: (207) 490-7998 |
News Archive
A quarter century after they discovered it, researchers have identified the job of one of the most common DNA-damage response proteins. The enzyme has puzzled scientists because it is present in nearly every organism, which suggests that it is crucial to life, and yet, in laboratory experiments, its function has remained a mystery.
A synthetic, anti-inflammatory and anti-allergic family of drugs to combat a variety of illnesses while avoiding detrimental side effects has been developed by a Hebrew University of Jerusalem researcher.
Working with mice and rabbits, Johns Hopkins scientists have found a way to block abnormal cholesterol production, transport and breakdown, successfully preventing the development of atherosclerosis, the main cause of heart attacks and strokes and the number-one cause of death among humans. The condition develops when fat builds inside blood vessels over time and renders them stiff, narrowed and hardened, greatly reducing their ability to feed oxygen-rich blood to the heart muscle and the brain.
Sirtex Medical Limited (ASX:SRX) today said sales of SIR-Spheres® microspheres, it's targeted radioactive treatment for inoperable liver cancer, grew 23% in the fourth quarter of the 2011 Financial Year compared with the same quarter last year. Full year dose sales grew 19.3% compared to a 14% growth the year before.
› Verified 3 days ago
George N Batty, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 27 Industrial Ave Ste 101, Sanford, ME 04073 Phone: 207-459-1666 | |
Mr. Harendra N Patel, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 27 June St, Sanford, ME 04073 Phone: 207-324-7126 Fax: 207-324-4308 | |
Shelly Ann Miller, Internal Medicine Medicare: Medicare Enrolled Practice Location: 25 June Street, Suite 111, Sanford, ME 04073 Phone: 207-490-7968 Fax: 207-490-7969 | |
Dr. Barbara P Mccall, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 25 June Street, Suite 111, Sanford, ME 04073 Phone: 207-324-5968 Fax: 207-490-1758 | |
Dr. Sara Jane Erickson, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1474 Main St, Sanford, ME 04073 Phone: 207-608-8442 Fax: 207-608-8443 | |
Dr. Anuja Sharma, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 25a June St, Suite 111, Sanford, ME 04073 Phone: 207-324-5968 Fax: 207-490-1758 |